Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Resectable Hepatocellular Carcinoma”

645 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 645 results

Testing effectiveness (Phase 2)Looking for participantsNCT07227012
What this trial is testing

Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Who this might be right for
Carcinoma, HepatocellularHepatocellular CancerHepatocellular Carcinoma+4 more
Pfizer 138
Not applicableLooking for participantsNCT05248581
What this trial is testing

Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer Metastatic
University of Rochester 25
Not applicableLooking for participantsNCT05667064
What this trial is testing

Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Who this might be right for
Unresectable Hepatocellular Carcinoma
AstraZeneca 300
Testing effectiveness (Phase 2)Looking for participantsNCT05992220
What this trial is testing

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatocellular Carcinoma Non-resectable+2 more
Asan Medical Center 138
Not applicableNo Longer AvailableNCT00701168
What this trial is testing

Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer

Who this might be right for
Carcinoma, HepatocellularNeoplasm Metastasis
Leo W. Jenkins Cancer Center
Testing effectiveness (Phase 2)Study completedNCT05517239
What this trial is testing

Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib Treatment

Who this might be right for
Hepatocellular Carcinoma, Unresectable, Advanced
Yonsei University 32
Not applicableUnknownNCT04523467
What this trial is testing

Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 320
Testing effectiveness (Phase 2)Study completedNCT00242502
What this trial is testing

Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
M.D. Anderson Cancer Center 62
Not applicableUnknownNCT04825470
What this trial is testing

Liver Transplantation for Unresectable GIST Liver Metastases

Who this might be right for
Liver DiseasesLiver CancerLiver Metastases+25 more
Hospital Universitario Virgen de la Arrixaca 50
Large-scale testing (Phase 3)UnknownNCT03780049
What this trial is testing

HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 304
Testing effectiveness (Phase 2)Study completedNCT00003557
What this trial is testing

Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
University of Chicago 16
Testing effectiveness (Phase 2)Study completedNCT00107536
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)UnknownNCT03851887
What this trial is testing

The Efficacy of Transarterial Chemoinfusion (TAI) Combine Stereotactic Body Radiation Therapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 33
Not applicableNot Yet RecruitingNCT07109336
What this trial is testing

Development and Prospective Validation of a Heterogeneous Treatment Effect-Based Decision Model for Transarterial Chemoembolization Combined With or Without Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Zhongda Hospital 790
Large-scale testing (Phase 3)Looking for participantsNCT05985798
What this trial is testing

Sintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 258
Testing effectiveness (Phase 2)Study completedNCT00003907
What this trial is testing

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

Who this might be right for
Liver CancerMetastatic Cancer
Eastern Cooperative Oncology Group 50
Not applicableWithdrawnNCT04231929
What this trial is testing

BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.

Who this might be right for
Hepatocellular Carcinoma
Terumo Europe N.V.
Large-scale testing (Phase 3)Active Not RecruitingNCT03298451
What this trial is testing

Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 1,324
Testing effectiveness (Phase 2)WithdrawnNCT03563170
What this trial is testing

QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine

Who this might be right for
Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma Recurrent
ImmunityBio, Inc.
Early research (Phase 1)Study completedNCT02578602
What this trial is testing

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular Carcinoma+6 more
University of Southern California 26
Load More Results